GENETIC VECTORS INC
8-A12B, 1996-11-15
PHARMACEUTICAL PREPARATIONS
Previous: GENETIC VECTORS INC, 8-A12G, 1996-11-15
Next: MILLENNIUM AMERICA INC, S-1/A, 1996-11-15



<PAGE>

                             FORM 8-A
                         
                         
                SECURITIES AND EXCHANGE COMMISSION
                      Washington D.C.  20549


        For Registration of Certain Classes of Securities
             Pursuant to Section 12(b) or (g) of the
                 Securities Exchange Act of 1934


                       GENETIC VECTORS, INC.
              -------------------------------------
              (Exact Name of Registrant as Specified
                         in its Charter)


           Florida                                    65-0324710
          ---------                                ---------------
(State or other jurisdiction of                   (I.R.S. Employer
incorporation or organization)                    Identification No.)



                     2000 South Dixie Highway
                            Suite 100
                      Miami, Florida  33133


      (Address of Registrant's principal executive offices)



Securities to be registered pursuant to Section 12(b) of the Act:

Title of Each Class to be          Name of Each Exchange on Which
so Registered                      Each Class is to be Registered
- -------------------------          ------------------------------


Common Stock, $.001 per share      Boston Stock Exchange


      If  this Form relates to the registration of a class of debt
securities  and  is  effective upon  filing  pursuant  to  General
Instruction A.(c)(1), please check the following box. [  ]

      If  this Form relates to the registration of debt securities
and  is  to become effective simultaneously with the effectiveness
of a concurrent registration statement under the Securities Act of
1933  pursuant to General Instruction A.(c)(2), please  check  the
following box.  [  ]

Securities to be registered pursuant to Section 12(g) of the Act:

                              NONE
<PAGE>



ITEM  1.       Description of Registrant's Securities to be Registered
               -------------------------------------------------------

            The information set forth under  the  caption, "Description  of
Securities," on pages 35 and 36 of the  Registrant's Preliminary Prospectus
that forms a part of Amendment No. 1 to the  Registration Statement on Form
SB-2 as filed by the Registrant with the Securities and Exchange Commission
(Registration  Number  333-5530-A)  on  October 25, 1996,  is  incorporated 
herein by reference.


ITEM 2.        Exhibits.
	       --------

            The following exhibits are filed as part of this  Registration
Statement with the copy thereof being filed with the Boston Stock Exchange
and the NASDAQ Small Cap Market:

          Exhibit                  Description
          -------                  -----------

             1.1              Amendment  No. 1  filed  with  the Securities
			      and Exchange Commission on October  25, 1996,
			      to  Registrant's  Registration  Statement  on
                              Form SB-2 (No. 333-5530-A)

            3.1               Articles of Incorporation of Genetic Vectors,
			      Inc., as amended

            3.2               Bylaws of Genetic Vectors, Inc.

           *4.1               Specimen of Certificate of Common  Stock, Par
			      Value $.001


*To be provided

                            SIGNATURE
                            ---------

            Pursuant  to the requirements of Section 12 of the Securities
Exchange Act of 1934, the Registrant has  duly  caused this  Registration
Statement to be signed on its  behalf  by  the undersigned, thereto  duly
authorized.




				GENETIC VECTORS, INC.


November  15,  1996            	By: /s/Mead M. McCabe, Jr., President
                                    -------------------------------
				    Mead M. McCabe, Jr., President


<PAGE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission